The research will focus on problem definition from three clinical fields: oncology (particularly breast, lung and prostate cancer), cardiovascular diseases and neuro(muscular) diseases. The research will concentrate on (combinations of) existing imaging technologies and new imaging technologies developed on those platforms: ultrasound, optics, magnetic resonance, X-rays and molecular imaging. Finally, four 'enablers' bring a third dimension to the strategic agenda to ensure accuracy, controllability, efficiency and effectiveness of research & development in medical imaging and its applications in diagnosis and treatment. The chosen enablers cover all imaging technology and disease areas. These are: targeted contrast agents, navigation technology, medical imaging informatics and MTA. The center will facilitate, stimulate and support knowledge transfer, education and entrepreneurship.


CMI-nen is founded by the University of Groningen (RuG)University Medical Center Groningen (UMCG)University of Twente (UT), and Siemens Netherlands. Each partner brings its own knowledge and experience into the mix, creating a powerful alliance.